CRP - Overview: C-Reactive Protein (CRP), Serum
Detecting systemic inflammatory processes Detecting infection and assessing response to antibiotic treatment of bacterial infections Differentiating between active and inactive disease forms with concurrent infection
CRETR - Overview: Creatinine, Random, Urine
Normalization of urinary analytes to account for the variation in urinary concentrations between individuals when using random urine collections
HYDMU - Overview: Hydromorphone Confirmation, Random, Urine
Detection and quantification of hydromorphone in urine
HYDCU - Overview: Hydrocodone with Metabolite Confirmation, Random, Urine
Detection and quantification of hydrocodone, norhydrocodone, and hydromorphone in urine
FL - Overview: Fluoride, Plasma
Assessing accidental fluoride ingestion Monitoring patients receiving sodium fluoride for bone disease or patients receiving voriconazole therapy
FELBA - Overview: Felbamate (Felbatol), Serum
Determining whether a poor therapeutic response is attributable to noncompliance or lack of drug effectiveness Monitoring changes in serum concentrations resulting from interactions with coadministered drugs such as barbiturates and...
FRUCT - Overview: Fructosamine, Serum
Monitoring intermediate (1-3 weeks) glycemic control Monitoring glycemic control in patients with shortened red blood cell survival
EHOLG - Overview: Entamoeba histolytica Antibody, Serum
As an adjunct in the diagnosis of extraintestinal, invasive amebiasis
10_IS - Overview: Factor X Inhibitor Screen, Plasma
Detecting the presence of a specific factor inhibitor directed against coagulation factor X
F7_IS - Overview: Factor VII Inhibitor Screen, Plasma
Detecting the presence of a specific factor inhibitor directed against coagulation factor VII
Category A - Mayo Clinic Laboratories
How do I determine if my specimen is a Category A infectious substance affecting humans? See Category A Infectious Substances. By law, an......
Guidance on subtyping of influenza A test results - Insights
Mayo Clinic Laboratories’ guidance for subtyping influenza A in response to a CDC advisory for hospitalized patients...
Category A Infectious Substances - Mayo Clinic Laboratories
Category A Infectious Substances The Dangerous Goods section of the International Air Transport Association (IATA) website provides a "Classification of Infectious Substances" document (pdf)...
Testing for Antibodies to SS-A/Ro in Autoimmune Diseases - Insights
In this month’s “Hot Topic,” Anne Tebo, Ph.D., discusses recent updates in the testing for anti-SS-A/Ro antibodies in systemic autoimmune rheumatic diseases....
A recent Mayo Clinic study has found that many U.S. health care providers are habitually ordering a mostly unnecessary, and quite expensive, genetic test to identify a patient’s hereditary risk of venous...